Impel NeuroPharma, Inc. reported consolidated earnings results for the first quarter ended March 31, 2021. For the quarter, the company reported a net loss of $11.4 million, compared to a net loss of $9.9 million for the same period in 2020. GAAP net loss per share totaled $15.09 per share in the first quarter of 2021 and $27.40 in the first quarter of 2020. Los from operations of $9,869,000 against $9,805,000 a year ago.